Vaxcyte Inc. (PCVX)
Market Open
26 Oct, 06:10 PM
$
59. 74
-0.69
-1.1418%
$
9.51B Market Cap
- P/E Ratio
- Div Yield
87,426 Volume
-3.49 Eps
$ 60.43
Previous Close 
Want to track PCVX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vaxcyte Inc. (PCVX) Statistics
Valuation metrics
Market Cap 9.51B
Enterprise value 9.44B
Trailing P/E (ttm) -7.91
Forward P/E -8.31
PEG ratio 0.16
Price/Sales (ttm) -
Price/Book (mrq) 3.17
Enterprise Value/Revenue -
Enterprise Value/EBITDA -9.01
Overview
Shares outstanding 131.06M
Float 132.23M
Shares short 13.69M
% Held by insiders 0.01%
% Held by institutions 1.05%
Average volume (10 days) 2.42M
Average volume (90 days) 1.99M
Price summary
52-Week low 39.87
52-Week high 90.75
Beta 1.39
50-Day moving average 61.76
200-Day moving average 57.34
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.34%
Return on equity -0.38%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -907.28M
Net income to common (ttm) -766.63M
Diluted EPS (ttm) -7.37
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 1.56B
Total cash per share (mrq) 10.29
Total debt (mrq) 117.48M
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 5.72%
Book value per share (mrq) 19.09
Cash Flow
Cash flow statement -655.58M
Levered free cash flow (LFCF) -430.85M
2026 © Marketlog. All Rights Reserved.
